D C Tormey
65 works · 4,368 citations · h-index 34
Top works
- Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
- HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
- Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.
- Phase I study of taxol administered as a short i.v. infusion daily for 5 days.
- Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
- Identification of transferrin as a lymphocyte growth promoter in human serum
- Evaluation of tamoxifen dose in advanced breast cancer: a progress report.
- Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
- Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III.
- Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy.
- Phase III Study of Bolus Versus Infusion Fluorouracil With or Without Cisplatin in Advanced Colorectal Cancer
- Steroid hormone receptors in normal human lymphocytes. Induction of glucocorticoid receptor activity by phytohemagglutinin stimulation.
- Effect of Prednisolone on Synthesis of DNA and RNA by Human Lymphocytes in vitro
- A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer.
- Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study.
- Biological effects of transferrin on human lymphocytes in vitro
- Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.
- Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death.
- Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer.
- Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study.